Androgens and male fertility

被引:291
作者
Dohle, GR
Smit, M
Weber, RFA
机构
[1] Erasmus Univ, Med Ctr, Dept Urol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Androl, Rotterdam, Netherlands
关键词
androgens; male infertility; spermatogenesis; testicular development; anabolic steroids;
D O I
10.1007/s00345-003-0365-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Androgens play a crucial role in the development of male reproductive organs such as the epididymis, vas deferens, seminal vesicle, prostate and the penis. Furthermore, androgens are needed for puberty, male fertility and male sexual function. High levels of intratesticular testosterone, secreted by the leydig cells, are necessary for spermatogenesis. Intratesticular testosterone is mainly bound to androgen binding protein and secreted into the seminiferous tubules. Inside the sertoli cells, testosterone is selectively bound to the androgen receptor and activation of the receptor will result in initiation and maintenance of the spermatogenic process and inhibition of germ cell apoptosis. The androgen receptor is found in all male reproductive organs and can be stimulated by either testosterone or its more potential metabolite dihydrotestosterone. Severe defects of the androgen receptor may result in abnormal male sexual development. More subtle modulations can be a potential cause of male infertility. Treatment of an infertile man with testosterone does improve spermatogenesis, since exogenous administrated testosterone and its metabolite estrogen will suppress both GnRH production by the hypothalamus and Luteinising hormone production by the pituitary gland and subsequently suppress testicular testosterone production. Also, high levels of testosterone are needed inside the testis and this can never be accomplished by oral or parenteral administration of androgens. Suppression of testosterone production by the leydig cells will result in a deficient spermatogenesis, as can be seen in men taking anabolic-androgenic steroids. Suppression of spermatogenesis by testosterone administration is also the basis for the development of a male contraceptive. During cytotoxic treatment or irradiation suppression of intratesticular testosterone production cells may prevent irreversible damage to the spermotogonial stem cells.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 29 条
  • [1] THE ANDROGEN RECEPTOR OF THE UROGENITAL TRACT OF THE FETAL-RAT IS REGULATED BY ANDROGEN
    BENTVELSEN, FM
    MCPHAUL, MJ
    WILSON, JD
    GEORGE, FW
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (01) : 21 - 26
  • [2] ANDROGEN RECEPTOR MUTATIONS
    BRINKMANN, AO
    JENSTER, G
    RISSTALPERS, C
    VANDERKORPUT, JAGM
    BRUGGENWIRTH, HT
    BOEHMER, ALM
    TRAPMAN, J
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 53 (1-6) : 443 - 448
  • [3] Cooper TG, 1996, ANDROLOGIA, V28, P57
  • [4] HORMONAL, HISTOLOGICAL AND CHROMOSOMAL STUDIES IN ADULT MALES WITH TESTICULAR DISORDERS
    DEKRETSE.DM
    BURGER, HG
    LONG, AR
    TAFT, HP
    FORTUNE, D
    HUDSON, B
    PAULSEN, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1972, 35 (03) : 392 - +
  • [5] Giwercman YL, 1998, CLIN GENET, V54, P435
  • [6] TESTICULAR DYSFUNCTION IN SYSTEMIC-DISEASE
    HANDELSMAN, DJ
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (04) : 839 - 856
  • [7] MAINTENANCE OF SPERMATOGENESIS INDUCED BY HMG TREATMENT BY MEANS OF CONTINUOUS HCG TREATMENT IN HYPOGONADOTROPIC MEN
    JOHNSEN, SG
    [J]. ACTA ENDOCRINOLOGICA, 1978, 89 (04): : 763 - 769
  • [8] KREUSER ED, 1993, EUR UROL, V23, P157
  • [9] ANDROGEN RECEPTOR GENE-MUTATIONS IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY
    LASPADA, AR
    WILSON, EM
    LUBAHN, DB
    HARDING, AE
    FISCHBECK, KH
    [J]. NATURE, 1991, 352 (6330) : 77 - 79
  • [10] Recombinant human follicle-stimulating hormone administration increases testosterone production in men, possibly by a Sertoli cell-secreted nonsteroid factor
    Levalle, O
    Zylbersztein, C
    Aszpis, S
    Aquilano, D
    Terradas, C
    Colombani, M
    Aranda, C
    Scaglia, H
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) : 3973 - 3976